This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global brain imaging modalities market was valued at $12,334.2 million in 2021 and is projected to reach $20,209.2 million by the end of 2031.
Market Report Coverage - Brain Imaging Modalities
Market Segmentation
- Product - CT Devices, MRI Devices, PET Devices, PET-CT Devices and PET-MRI Devices
- Patient Type - Adults and Pediatrics and Infants
- End User - Hospitals and Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical Centers
Regional Segmentation
- North America - U.S. and Canada
- Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe
- Asia-Pacific - Japan, China, South Korea, India, Australia and New Zealand, and Rest-of-Asia-Pacific
- Rest-of-the-World - Latin America, and Middle East and Africa
Market Growth Drivers
- Rising Prevalence of Neurological Disorders and Traumatic Brain Injuries (TBI)
- Technological Advancements in the Brain Imaging Modalities and Systems
- Growing Popularity of Molecular Imaging in Brain Imaging
Market Challenges
- Hospital Budget Cuts and High Upfront Cost
- Declining Helium Availability
Market Opportunities
- Integration of Imaging Systems and Software with Novel Biomarkers
Key Companies Profiled
Aspect Imaging, Canon, Inc., Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hyperfine Inc., Koninklijke Philips N.V., Mediso Medical Imaging Systems, MinFound Medical Systems Co., Ltd., Samsung Electronics Co., Ltd., Shenzhen Anke High-Tech Co.,Ltd., Shimadzu Corporation, Siemens Healthineers AG, United Imaging Healthcare Co., Ltd., VUNO Co., Ltd.
How This Report Can Add Value
Assuming that the reader is a manufacturer of brain imaging modalities, the report will assist them in the following ways:
- Understand their position compared to other key players in the market
- Stay updated with novel technology integration, features, and the latest developments in the market
- Understand the impact of COVID-19 on brain imaging and the entry barriers for new companies
- Gain insights into end-user perception concerning the brain imaging modalities market
- Identify some key players in the market and understand their valuable contribution
Key Questions Answered in the Report
- How has COVID-19 impacted the growth of the global brain imaging modalities market?
- What are the key regulations governing the brain imaging modalities market in key regions?
- What technological developments are projected to have the maximum influence on the global brain imaging modalities market?
- Who are the leading players holding significant dominance in the global brain imaging modalities market?
- What are some of the growth opportunities which market players can capitalize on?
- What are the drivers and restraints for the global brain imaging modalities market?
- Which region has the highest growth rate in the brain imaging modalities market?
- Which are the fastest growing countries in terms of the global brain imaging modalities market?
- What are the key strategies being adopted by market players in the global brain imaging modalities market?
- Which are the emerging companies in the global brain imaging modalities market?
Global Brain Imaging Modalities Market Industry Overview
The global brain imaging modalities market is projected to witness significant growth during the forecast period 2022-2031. The high prevalence and growing incidences of brain diseases and neurogenerative disorders and the technological advancements in brain imaging modalities and systems are the key propellers for the growth of the market. Five key modalities of brain imaging modalities include computed tomography (CT) devices, magnetic resonance imaging (MRI) devices, positron emission tomography (PET) devices, PET-CT devices, and PET MRI devices. The field of cognitive neuroscience has emerged and developed rapidly over the last 20 years. To address the neural underpinnings of human cognition, this new field combines two traditionally separate disciplines, cognitive psychology and neurology.
The market for brain imaging modalities devices is rapidly growing, with an increasing number of modalities used in the imaging of various brain diseases and neurogenerative disorders (NDs). The high prevalence and growing incidences of neurological disorders (NDs) are one of the major factors augmenting the growth of the global brain imaging modalities market. Neurological diseases and mental disorders have emerged as serious public health concerns and substantial challenges to healthcare systems around the world. Genetic disorders, congenital anomalies or disorders, infections, lifestyle, or environmental health problems such as malnutrition, brain injury, spinal cord injury, or nerve injury are some of the causes of neurological problems.
The global brain imaging modalities market report highlights that the market was valued at $12,334.2 million in 2021 and is expected to reach $20,209.2 million by the end of 2031. The market is expected to grow at a CAGR of 5.06% during the forecast period 2022-2031.
Global Brain Imaging Modalities Market Drivers
Personalized and tailored treatment approaches based on monitoring and imaging findings and respecting pre-injury comorbidities and their therapies are warranted due to traumatic brain injury is a syndrome encompassing a variety of different affections to the brain, and since age-related comorbidities and treatments may also have a significant impact. More importantly, as the prevalence and incidence of neurological illnesses continue to rise, so will technological adoption. As a result, the growth of disease diagnosis and, as a result, the global market for brain imaging modalities will accelerate.
Governments invest a significant amount of money in healthcare insurance so that the overall healthcare costs can be reduced, and the quality of life and affordability of the treatment can be enhanced.
Global Brain Imaging Modalities Market Restraints
The factors restraining the growth of the global brain imaging devices market include the risks associated with radiation exposure and delay in regulatory approvals. Delay in regulatory approval for the products due to the stringent government regulations concerning the use of AI-enabled software in medical imaging hinders the market's growth. Moreover, another factor restraining the growth of the global brain imaging devices market is the high cost associated with medical imaging.
Global Brain Imaging Modalities Market Opportunities
High growth opportunities in emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global brain imaging modalities market growth. In an era of machine learning and artificial intelligence, extracting quantitative biomarkers from medical images to aid illness detection, characterization, monitoring, and therapy response assessment is becoming increasingly desirable.
Impact of COVID-19 on the Global Brain Imaging Modalities Market
The COVID-19 pandemic had a debilitating impact on the global healthcare ecosystem. Hospitals and clinics faced several challenges such as lack of resources, high patient influx, and risk of infection among care providers. The market is projected to witness considerable growth during the forecast period 2021-2030. The increasing innovations and product designs in the global market and the growing use in emerging economies are the driving factors for the growth of the market.
Market Segmentation
Global Brain Imaging Modalities Market (by Product Type)
The global brain imaging modalities market, based on product type, has been segmented into CT devices, MRI devices, PET devices, PET-CT devices, and PET-MRI devices.
Global Brain Imaging Modalities Market (by Patient Type)
The global brain imaging modalities market, based on patient type, has been segmented into adults, and pediatrics and infants.
Global Brain Imaging Modalities Market (by End User)
The global brain imaging modalities market, based on end user, has been segmented into hospitals and clinics, diagnostic imaging centers, and ambulatory surgery centers surgical centers.
Hospitals and clinics are the major end users for the global brain imaging modalities market. The high volume of the end user makes them the primary diagnosis site for brain diseases and neurodegenerative disorders (NDs) in emerging economies. Furthermore, the adoption of brain imaging modalities in ASCs has been increased due to several factors such as personalized care to the patients and reduced recovery time.
Global Brain Imaging Modalities Market (by Region)
The different regions covered under the global brain imaging modalities market include North America, Europe, Asia-Pacific and Rest-of-the-World.
North America is expected to be the most lucrative region for the global brain imaging modalities market due to advanced healthcare infrastructure and a high focus on research and development activities. The Asia-Pacific brain imaging modalities market is one of the lucrative markets with immense potential for expansion by key players of the global brain imaging modalities market. The Asia-Pacific brain imaging modalities market is expected to grow at the fastest rate during the forecast period. This can be attributed to the massive geriatric population base, which is driving the increase in the volume of brain imaging modalities.
Key Market Players and Competition Synopsis
Some key players operating in the market include Aspect Imaging, Canon, Inc., Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hyperfine Inc., Koninklijke Philips N.V., Mediso Medical Imaging Systems, MinFound Medical Systems Co., Ltd., Samsung Electronics Co., Ltd., Shenzhen Anke High-Tech Co.,Ltd., Shimadzu Corporation, Siemens Healthineers AG, United Imaging Healthcare Co., Ltd., and VUNO Co., Ltd.
Some strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, business expansion, regulatory and legal activities, and new offerings.
Table of Contents
1 Markets
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.1.4 Assumptions and Limitations
1.1.5 Global Market Scenario
1.1.5.1 Realistic Growth Scenario
1.1.5.2 Optimistic Growth Scenario
1.1.5.3 Pessimistic/Conservative Growth Scenario
1.2 Industry Outlook
1.2.1 Key Trends
1.2.2 Opportunity Assessment
1.2.2.1 Short-Term Potential
1.2.2.2 Long-Term Potential
1.2.3 Patent Analysis
1.2.3.1 Awaited Technological Developments
1.2.3.2 Patent Publication Growth Trend
1.2.3.3 Patent Analysis by Country/Cluster
1.2.4 Product Benchmarking
1.3 Impact of COVID-19
1.3.1 Impact on Facilities
1.3.2 Impact on Device Adoption
1.3.3 Impact on Market Size
1.3.3.1 Pre-COVID-19 Phase
1.3.3.2 During COVID-19 Phase
1.3.3.3 Post-COVID-19 Phase
1.4 Business Dynamics
1.4.1 Impact Analysis
1.4.2 Business Drivers
1.4.2.1 Rising Prevalence of Neurological Disorders and Traumatic Brain Injuries (TBI)
1.4.2.2 Technological Advancements in the Brain Imaging Modalities and Systems
1.4.2.3 Growing Popularity of Molecular Imaging in Brain Imaging
1.4.3 Business Restraints
1.4.3.1 Hospital Budget Cuts and High Upfront Cost
1.4.3.2 Declining Helium Availability
1.4.4 Business Opportunities
1.4.4.1 Integration of Imaging Systems and Software with Novel Biomarkers
2 Application
2.1 Global Brain Imaging Modalities Market (by Patient Type)
2.1.1 Opportunity Assessment
2.1.2 Growth-Share Matrix
2.1.3 Adults
2.1.3.1 Market Trends
2.1.3.2 Market Size and Forecast
2.1.4 Pediatrics and Infants
2.1.4.1 Market Trends
2.1.4.2 Market Size and Forecast
2.2 Global Brain Imaging Modalities Market (by End User)
2.2.1 Opportunity Assessment
2.2.2 Growth-Share Matrix
2.2.3 Hospitals and Clinics
2.2.4 Diagnostic Imaging Centers
2.2.5 Ambulatory Surgical Centers
3 Product
3.1 Global Brain Imaging Modalities Market (by Product)
3.1.1 Opportunity Assessment
3.1.2 Market Share Analysis
3.1.3 Growth-Share Matrix
3.1.3.1 Competitive Benchmarking
3.1.4 CT Devices
3.1.4.1 Current Market Scenario, Key Findings
3.1.4.2 Key Trends
3.1.4.3 Production Volume
3.1.4.3.1 North America
3.1.4.3.2 Europe
3.1.4.3.3 Asia-Pacific
3.1.4.3.4 Rest-of-the-World
3.1.4.4 Market Size and Forecast
3.1.4.5 Vendor Analysis
3.1.4.5.1 Market Share (by Vendor)
3.1.4.5.2 Production Volume (by Vendor)
3.1.5 MRI Devices
3.1.5.1 Current Market Scenario (Key Findings)
3.1.5.2 Key Trends
3.1.5.3 Production Volume
3.1.5.3.1 North America
3.1.5.3.2 Europe
3.1.5.3.3 Asia-Pacific
3.1.5.3.4 Rest-of-the-World
3.1.5.4 Market Size and Forecast
3.1.5.5 2D and 3D MRI Ratio
3.1.5.5.1 U.S.
3.1.5.5.2 EU5
3.1.5.5.3 Japan
3.1.5.5.4 South Korea
3.1.5.6 Vendor Analysis
3.1.5.6.1 Market Share (by Vendor)
3.1.5.6.2 Production Volume (by Vendor)
3.1.6 PET Devices
3.1.6.1 Current Market Scenario, Key Findings
3.1.6.2 Key Trends
3.1.6.3 Production Volume
3.1.6.3.1 North America
3.1.6.3.2 Europe
3.1.6.3.3 Asia-Pacific
3.1.6.3.4 Rest-of-the-World
3.1.6.4 Market Size and Forecast
3.1.6.1 Vendor Analysis
3.1.6.1.1 Market Share (by Vendor)
3.1.6.1.2 Production Volume (by Vendor)
3.1.7 PET-CT Devices
3.1.7.1 Current Market Scenario, Key Findings
3.1.7.2 Key Trends
3.1.7.3 Production Volume
3.1.7.3.1 North America
3.1.7.3.2 Europe
3.1.7.3.3 Asia-Pacific
3.1.7.3.4 Rest-of-the-World
3.1.7.4 Market Size and Forecast
3.1.7.5 Vendor Analysis
3.1.7.5.1 Market Share (by Vendor)
3.1.7.5.2 Production Volume (by Vendor)
3.1.8 PET-MRI Devices
3.1.8.1 Current Market Scenario, Key Findings
3.1.8.2 Key Trends
3.1.8.3 Production Volume
3.1.8.3.1 North America
3.1.8.3.2 Europe
3.1.8.3.3 Asia-Pacific
3.1.8.3.4 Rest-of-the-World
3.1.8.4 Market Size and Forecast
3.1.8.5 Vendor Analysis
3.1.8.5.1 Market Share (by Vendor)
3.1.8.5.2 Production Volume (by Vendor)
4 Region
4.1 North America Brain Imaging Modalities Market
4.1.1 Regulatory Framework
4.1.2 Market
4.1.2.1 Key Findings and Opportunity Assessment
4.1.2.2 Market Dynamics
4.1.2.2.1 Impact Analysis
4.1.2.3 Sizing and Forecast Analysis
4.1.3 Application
4.1.3.1 North America Brain Imaging Modalities Market (by Patient Type)
4.1.3.2 North America Brain Imaging Modalities Market (by End User)
4.1.4 Product
4.1.4.1 North America Brain Imaging Modalities Market (by Product Type)
4.1.5 North America Brain Imaging Modalities Market (by Country)
4.1.5.1 U.S.
4.1.5.2 Canada
4.2 Europe Brain Imaging Modalities Market
4.2.1 Regulatory Framework
4.2.2 Market
4.2.2.1 Key Findings and Opportunity Assessment
4.2.2.2 Market Dynamics
4.2.2.2.1 Impact Analysis
4.2.2.3 Sizing and Forecast Analysis
4.2.3 Application
4.2.3.1 Europe Brain Imaging Modalities Market (by Patient Type)
4.2.3.2 Europe Brain Imaging Modalities Market (by End User)
4.2.4 Product
4.2.4.1 Europe Brain Imaging Modalities Market (by Product)
4.2.5 Europe Brain Imaging Modalities Market (by Country)
4.2.5.1 Germany
4.2.5.2 France
4.2.5.3 U.K.
4.2.5.4 Italy
4.2.5.5 Spain
4.2.5.6 Rest-of-Europe
4.3 Asia-Pacific Brain Imaging Modalities Market
4.3.1 Regulatory Framework
4.3.2 Market
4.3.2.1 Key Findings and Opportunity Assessment
4.3.2.2 Market Dynamics
4.3.2.2.1 Impact Analysis
4.3.2.1 Sizing and Forecast Analysis
4.3.3 Application
4.3.3.1 Asia-Pacific Brain Imaging Modalities Market (by Patient Type)
4.3.3.2 Asia-Pacific Brain Imaging Modalities Market (by End User)
4.3.4 Product
4.3.4.1 Asia-Pacific Brain Imaging Modalities Market (by Product Type)
4.3.5 Asia-Pacific Brain Imaging Modalities Market (by Country)
4.3.5.1 China
4.3.5.2 Japan
4.3.5.3 India
4.3.5.4 South Korea
4.3.5.5 Australia and New Zealand
4.3.5.6 Rest-of-Asia-Pacific
4.4 Rest-of-the-World Brain Imaging Modalities Market
4.4.1 Regulatory Framework
4.4.2 Market
4.4.2.1 Key Findings and Opportunity Assessment
4.4.2.2 Market Dynamics
4.4.2.2.1 Impact Analysis
4.4.2.3 Sizing and Forecast Analysis
4.4.3 Application
4.4.3.1 Rest-of-the-World Brain Imaging Modalities Market (by Patient Type)
4.4.3.2 Rest-of-the-World Brain Imaging Modalities Market (by End User)
4.4.4 Product
4.4.4.1 Rest-of-the-World Brain Imaging Modalities Market (by Product Type)
4.4.5 Rest-of-the-World Brain Imaging Modalities Market (by Country)
4.4.5.1 Latin America
4.4.5.2 Middle East and Africa
5 Market- Company Profiles and Competitive Benchmarking
5.1 Competitive Landscape
5.1.1 Key Strategies and Developments
5.1.1.1 Regulatory and Legal Activities
5.1.1.2 New Product Offerings and Upgradations
5.1.1.3 Partnerships, Alliances, and Business Expansion
5.1.1.4 Funding Activities
5.1.1.5 Mergers and Acquisitions
5.2 Market Share Analysis
5.3 Company Profiles
5.3.1 Aspect Imaging
5.3.1.1 Company Overview
5.3.1.2 Role of Aspect Imaging in the Global Brain Imaging Modalities Market
5.3.1.3 Product Portfolio and Offerings
5.3.1.4 Aspect Imaging: SWOT Analysis
5.3.2 Canon, Inc.
5.3.2.1 Company Overview
5.3.2.2 Role of Canon, Inc. in the Global Brain Imaging Modalities Market
5.3.2.3 Product Portfolio and Offerings
5.3.2.4 Recent Developments
5.3.2.5 Financials
5.3.2.6 Canon, Inc.: SWOT Analysis
5.3.3 Esaote SpA
5.3.3.1 Company Overview
5.3.3.2 Role of Esaote SpA in the Global Brain Imaging Modalities Market
5.3.3.3 Product Portfolio and Offerings
5.3.3.4 Esaote SpA: SWOT Analysis
5.3.4 Fujifilm Holdings Corporation
5.3.4.1 Company Overview
5.3.4.2 Role of Fujifilm Holdings Corporation in the Global Brain Imaging Modalities Market
5.3.4.3 Product Portfolio and Offerings
5.3.4.4 Financials
5.3.4.5 Recent Developments
5.3.4.6 Fujifilm Holdings Corporation: SWOT Analysis
5.3.5 General Electric Company
5.3.5.1 Company Overview
5.3.5.2 Role of General Electric Company in the Global Brain Imaging Modalities Market
5.3.5.3 Product Portfolio and Offerings
5.3.5.4 Financials
5.3.5.5 General Electric Company: SWOT Analysis
5.3.6 Hyperfine Inc.
5.3.6.1 Company Overview
5.3.6.2 Role of Hyperfine Inc. in the Global Brain Imaging Modalities Market
5.3.6.3 Product Portfolio and Offerings
5.3.6.4 Recent Developments
5.3.6.5 Hyperfine Inc.: SWOT Analysis
5.3.7 Koninklijke Philips N.V.
5.3.7.1 Company Overview
5.3.7.2 Role of Koninklijke Philips N.V. in the Global Brain Imaging Modalities Market
5.3.7.3 Product Portfolio and Offerings
5.3.7.4 Financials
5.3.7.5 Koninklijke Philips N.V.: SWOT Analysis
5.3.8 Mediso Medical Imaging Systems
5.3.8.1 Company Overview
5.3.8.2 Role of Mediso Medical Imaging Systems in the Global Brain Imaging Modalities Market
5.3.8.3 Product Portfolio and Offerings
5.3.8.4 Mediso Medical Imaging Systems: SWOT Analysis
5.3.9 MinFound Medical Systems Co., Ltd.
5.3.9.1 Company Overview
5.3.9.2 Role of MinFound Medical Systems Co., Ltd. in the Global Brain Imaging Modalities Market
5.3.9.3 Product Portfolio and Offerings
5.3.9.4 MinFound Medical Systems Co., Ltd.: SWOT Analysis
5.3.10 Samsung Electronics Co., Ltd.
5.3.10.1 Company Overview
5.3.10.2 Role of Samsung Electronics Co., Ltd. in the Global Brain Imaging Modalities Market
5.3.10.3 Product Portfolio and Offerings
5.3.10.4 Financials
5.3.10.5 Samsung Electronics Co., Ltd.: SWOT Analysis
5.3.11 Shenzhen Anke High-Tech Co.,Ltd.
5.3.11.1 Company Overview
5.3.11.2 Role of Shenzhen Anke High-Tech Co., Ltd. in the Global Brain Imaging Modalities Market
5.3.11.3 Product Portfolio and Offerings
5.3.11.4 Shenzhen Anke High-Tech Co., Ltd.: SWOT Analysis
5.3.12 Shimadzu Corporation
5.3.12.1 Company Overview
5.3.12.2 Role of Shimadzu Corporation in the Global Brain Imaging Modalities Market
5.3.12.3 Product Portfolio and Offerings
5.3.12.4 Financials
5.3.12.5 Recent Developments
5.3.12.6 Shimadzu Corporation: SWOT Analysis
5.3.13 Siemens Healthineers AG
5.3.13.1 Company Overview
5.3.13.2 Role of Siemens Healthineers AG in the Global Brain Imaging Modalities Market
5.3.13.3 Product Portfolio and Offerings
5.3.13.4 Financials
5.3.13.5 Recent Developments
5.3.13.6 Siemens Healthineers AG: SWOT Analysis
5.3.14 United Imaging Healthcare Co., Ltd.
5.3.14.1 Company Overview
5.3.14.2 Role of United Imaging Healthcare Co., Ltd. in the Global Brain Imaging Modalities Market
5.3.14.3 Product Portfolio and Offerings
5.3.14.4 Recent Developments
5.3.14.5 United Imaging Healthcare Co., Ltd.: SWOT Analysis
5.3.15 VUNO Co., Ltd.
5.3.15.1 Company Overview
5.3.15.2 Role of VUNO Co., Ltd. in the Global Brain Imaging Modalities Market
5.3.15.3 Product Portfolio and Offerings
5.3.15.4 Recent Developments
5.3.15.5 VUNO Co., Ltd.: SWOT Analysis
6 Research Methodology
6.1 Data Collection and Analysis
6.2 Data Sources
6.2.1 Primary Data Sources
6.2.2 Secondary Data Sources
6.3 Data Triangulation
6.4 Market Estimation
6.5 Forecast Period Selection Criteria
6.6 Assumptions and Limitations
List of Figures
Figure 1: Global Brain Imaging Modalities Market, Impact Analysis
Figure 2: Global Brain Imaging Modalities Market Potential, $Million, 2020, 2024, 2027, and 2031
Figure 3: Global Brain Imaging Modalities Market (by Product Type)
Figure 4: Global Brain Imaging Modalities Market (by End User)
Figure 5: Key Developments and Strategies, January 2017-December 2021
Figure 6: Global Brain Imaging Modalities Market Growth-Share Matrix, 2021-2031
Figure 7: Global Brain Imaging Modalities Coverage
Figure 8: Global Brain Imaging Modalities Market, Realistic Growth Scenario, $Million, 2020-2031
Figure 9: Global Brain Imaging Modalities Market, Optimistic Growth Scenario, $Million, 2020-2031
Figure 10: Global Brain Imaging Modalities Market, Pessimistic Growth Scenario, $Million, 2020-2031
Figure 11: Global Brain Imaging Modalities Market, Short-Term Potential, $Million, 2022-2025
Figure 12: Global Brain Imaging Modalities Market, Long-Term Growth, $Million, 2026-2031
Figure 13: Global Brain Imaging Modalities Market, Patent Publication Growth Trend, January 2018-December 2021
Figure 14: Global Brain Imaging Modalities Market, Patent Filing Trend (by Country/Cluster), January 2018-December 2021
Figure 15: Pre-COVID-19 Scenario, Global Brain Imaging Modalities Market
Figure 16: Global Brain Imaging Modalities Market, Impact Analysis
Figure 17: Technological Advancements in Brain Imaging
Figure 18: Molecular Imaging Techniques: General Characteristics
Figure 19: Global Brain Imaging Modalities Market (by Patient Type)
Figure 20: Global Brain Imaging Modalities Market Incremental Opportunity (by Patient Type), $Million, 2022-2031
Figure 21: Global Brain Imaging Modalities Market, Growth-Share Matrix (by Patient Type), 2020-2031
Figure 22: Global Brain Imaging Modalities Market (by Adults), $Million, 2020-2031
Figure 23: Global Brain Imaging Modalities Market (by Pediatrics and Infants), $Million, 2020-2031
Figure 24: Global Brain Imaging Modalities Market (by End User)
Figure 25: Global Brain Imaging Modalities Market Incremental Opportunity (by End User), $Million, 2022-2031
Figure 26: Global Brain Imaging Modalities Market, Growth-Share Matrix (by End User), 2020-2031
Figure 27: Global Brain Imaging Modalities Market (by Hospitals and Clinics), $Million, 2020-2031
Figure 28: Global Brain Imaging Modalities Market (by Diagnostic Imaging Centers), $Million, 2020-2031
Figure 29: Global Brain Imaging Modalities Market (by Ambulatory Surgical Centers), $Million, 2020-2031
Figure 30: Global Brain Imaging Modalities Market (by Product Type)
Figure 31: Global Brain Imaging Modalities Market Incremental Opportunity (by Product Type), $Million, 2022-2031
Figure 32: Market Share by Product Type, 2021
Figure 33: Global Brain Imaging Modalities Market, Growth-Share Matrix (by Product Type), 2020-2031
Figure 34: Global Brain Imaging Market Competitive Benchmarking (by Key Players)
Figure 35: Global Brain Imaging Modalities Incremental Opportunity Analysis (CT Devices), 2022-2031
Figure 36: CT Devices, Key Trends
Figure 37: Global Brain Imaging Modalities Market (by CT Devices), $Million, 2020-2031
Figure 38: CT Devices, Market Share (by Vendor), 2021
Figure 39: Global Brain Imaging Modalities Incremental Opportunity Analysis (CT Devices), 2022-2031
Figure 40: MRI Devices, Key Trends
Figure 41: Global Brain Imaging Modalities Market (by MRI Devices), $Million, 2020-2031
Figure 42: 2D and 3D MRI Ratio
Figure 43: MRI Devices, Market Share (by Vendor), 2021
Figure 44: Global Brain Imaging Modalities Incremental Opportunity Analysis (PET Devices), 2022-2031
Figure 45: PET Devices, Key Trends
Figure 46: Global Brain Imaging Modalities Market (by PET Devices), $Million, 2020-2031
Figure 47: PET Devices, Market Share Analysis (by Vendor), 2021
Figure 48: Global Brain Imaging Modalities Incremental Opportunity Analysis (PET-CT Devices), 2022-2031
Figure 49: PET-CT Devices, Key Trends
Figure 50: Global Brain Imaging Modalities Market (by PET-CT Devices), $Million, 2020-2031
Figure 51: PET-CT Devices, Market Share (by Vendor), 2021
Figure 52: Global Brain Imaging Modalities Incremental Opportunity Analysis (PET-MRI Devices), 2022-2031
Figure 53: PET-MRI Devices, Key Trends
Figure 54: Global Brain Imaging Modalities Market (PET-MRI Devices), $Million, 2020-2031
Figure 55: PET-MRI Devices, Market Share Analysis (by Vendor), 2021
Figure 56: Global Brain Imaging Modalities Market (by Region), 2021 and 2031
Figure 57: North America Brain Imaging Modalities Market Incremental Growth Opportunity (by Country), $Million, 2022-2031
Figure 58: North America Brain Imaging Modalities Market, $Million, 2020-2031
Figure 59: North America Brain Imaging Modalities Market (by Patient Type), $Million, 2020-2031
Figure 60: North America Brain Imaging Modalities Market (by End User), $Million, 2020-2031
Figure 61: North America Brain Imaging Modalities Market (by Product Type), $Million, 2020-2031
Figure 62: U.S. Brain Imaging Modalities Market, $Million, 2020-2031
Figure 63: Canada Brain Imaging Modalities Market, $Million, 2020-2031
Figure 64: Europe Brain Imaging Modalities Market Incremental Growth Opportunity, $Million, 2022-2031
Figure 65: Europe Brain Imaging Modalities Market, $Million, 2020-2031
Figure 66: Europe Brain Imaging Modalities Market (by Patient Type), $Million, 2020-2031
Figure 67: Europe Brain Imaging Modalities Market (by End User), $Million, 2020-2031
Figure 68: Europe Brain Imaging Modalities Market (by Product), $Million, 2020-2031
Figure 69: Germany Brain Imaging Modalities Market, $Million, 2020-2031
Figure 70: France Brain Imaging Modalities Market, $Million, 2020-2031
Figure 71: U.K. Brain Imaging Modalities Market, $Million, 2020-2031
Figure 72: Italy Brain Imaging Modalities Market, $Million, 2020-2031
Figure 73: Spain Brain Imaging Modalities Market, $Million, 2020-2031
Figure 74: Rest-of-Europe Brain Imaging Modalities Market, $Million, 2020-2031
Figure 75: Asia-Pacific Brain Imaging Modalities Market Incremental Growth Opportunity, $Million, 2022-2031
Figure 76: Asia-Pacific Brain Imaging Modalities Market, $Million, 2020-2031
Figure 77: Asia-Pacific Brain Imaging Modalities Market (by Patient Type), $Million, 2020-2031
Figure 78: Asia-Pacific Brain Imaging Modalities Market (by End User), $Million, 2020-2031
Figure 79: Asia-Pacific Brain Imaging Modalities Market (by Product Type), $Million, 2020-2031
Figure 80: China Brain Imaging Modalities Market, $Million, 2020-2031
Figure 81: Japan Brain Imaging Modalities Market, $Million, 2020-2031
Figure 82: India Brain Imaging Modalities Market, $Million, 2020-2031
Figure 83: South Korea Brain Imaging Modalities Market, $Million, 2020-2031
Figure 84: Australia and New Zealand Brain Imaging Modalities Market, $Million, 2020-2031
Figure 85: Rest-of-Asia-Pacific Brain Imaging Modalities Market, $Million, 2020-2031
Figure 86: Rest-of-the-World Brain Imaging Modalities Market Incremental Growth Opportunity, $Million, 2022-2031
Figure 87: Rest-of-the-World Brain Imaging Modalities Market, $Million, 2020-2031
Figure 88: Rest-of-the-World Brain Imaging Modalities Market (by Patient Type), $Million, 2020-2031
Figure 89: Rest-of-the-World Brain Imaging Modalities Market (by End User), $Million, 2020-2031
Figure 90: Rest-of-the-World Brain Imaging Modalities Market (by Product Type), $Million, 2020-2031
Figure 91: Latin America Brain Imaging Modalities Market, $Million, 2020-2031
Figure 92: Middle East and Africa Brain Imaging Modalities Market, $Million, 2020-2031
Figure 93: Share of Key Developments and Strategies, January 2017-December 2021
Figure 94: Regulatory and Legal Activities Share (by Company), January 2017-December 2021
Figure 95: New Product Offerings and Upgradations Share (by Company), January 2017-December 2021
Figure 96: Partnerships, Alliances, and Business Expansion Share (by Company), January 2017-December 2021
Figure 97: Mergers and Acquisitions Share (by Company), January 2017-December 2021
Figure 98: Market Share Analysis (by Company), 2021
Figure 99: Aspect Imaging: Product Offerings
Figure 100: Canon, Inc.: Product Offerings
Figure 101: Canon, Inc.: Overall Financials, $Million, 2018-2020
Figure 102: Canon, Inc.: Net Revenue (by Segment), $Million, 2018-2020
Figure 103: Canon, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 104: Canon, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 105: Esaote SpA: Product Offerings
Figure 106: Fujifilm Holdings Corporation: Product Offerings
Figure 107: Fujifilm Holdings Corporation: Overall Financials, $Million, 2018-2020
Figure 108: Fujifilm Holdings Corporation: Net Revenue (by Segment), $Million, 2018-2020
Figure 109: Fujifilm Holdings Corporation: Net Revenue (by Region), $Million, 2018-2020
Figure 110: Fujifilm Holdings Corporation: R&D Expenditure, $Million, 2018-2020
Figure 111: General Electric Company: Product Offerings
Figure 112: General Electric Company.: Overall Financials, $Million, 2018-2020
Figure 113: General Electric Company: Net Revenue (by Segment), $Million, 2018-2020
Figure 114: General Electric Company: Net Revenue (by Region), $Million, 2018-2020
Figure 115: General Electric Company: R&D Expenditure, $Million, 2018-2020
Figure 116: Hyperfine Inc.: Product Offerings
Figure 117: Koninklijke Philips N.V.: Product Offerings
Figure 118: Koninklijke Philips N.V.: Overall Financials, $Million, 2018-2020
Figure 119: Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2018-2020
Figure 120: Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2018-2020
Figure 121: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2018-2020
Figure 122: Mediso Medical Imaging Systems: Product Offerings
Figure 123: MinFound Medical Systems Co., Ltd.: Product Offerings
Figure 124: Samsung Electronics Co., Ltd.: Product Offerings
Figure 125: Samsung Electronics Co., Ltd.: Overall Financials, $Million, 2018-2020
Figure 126: Samsung Electronics Co., Ltd.: Net Revenue (by Segment), $Million, 2018-2020
Figure 127: Samsung Electronics Co., Ltd.: Net Revenue (by Region), $Million, 2018-2020
Figure 128: Samsung Electronics Co., Ltd.: R&D Expenditure, $Million, 2018-2020
Figure 129: Shenzhen Anke High-Tech Co., Ltd.: Product Offerings
Figure 130: Shimadzu Corporation: Product Offerings
Figure 131: Shimadzu Corporation: Overall Financials, $Million, 2018-2020
Figure 132: Shimadzu Corporation: Net Revenue (by Segment), $Million, 2018-2020
Figure 133: Shimadzu Corporation: Net Revenue (by Region), $Million, 2018-2020
Figure 134: Shimadzu Corporation: R&D Expenditure, $Million, 2018-2020
Figure 135: Siemens Healthineers AG: Product Offerings
Figure 136: Siemens Healthineers AG: Overall Financials, $Million, 2019-2021
Figure 137: Siemens Healthineers AG: Net Revenue (by Segment), $Million, 2019-2021
Figure 138: Siemens Healthineers AG: Net Revenue (by Region), $Million, 2019-2021
Figure 139: Siemens Healthineers AG: R&D Expenditure, $Million, 2019-2021
Figure 140: United Imaging Healthcare Co., Ltd.: Product Offerings
Figure 141: VUNO Co., Ltd.: Product Offerings
Figure 142: Global Brain Imaging Modalities Market: Research Methodology
Figure 143: Primary Research
Figure 144: Secondary Research
Figure 145: Data Triangulation
Figure 146: Global Brain Imaging Modalities Market Research Process
Figure 147: Assumptions and Limitations
List of Tables
Table 1: Challenges in the Global Brain Imaging Modalities Market
Table 2: Global Brain Imaging Modalities Market, Key Trends
Table 3: Global Brain Imaging Modalities Market, Awaited Technology Developments
Table 4: Global Brain Imaging Modalities Market, Product Benchmarking
Table 5: Global Brain Imaging Modalities Market, Key Trends (by Adults)
Table 6: Global Brain Imaging Modalities Market, Key Trends (by Pediatrics and Infants)
Table 7: CT Devices, Production Volume (by Region)
Table 8: CT Devices, Production Volume (by Vendor)
Table 9: MRI Devices, Production Volume (by Region)
Table 10: MRI Devices, Production Volume (by Vendor)
Table 11: PET Devices, Production Volume (by Region)
Table 12: PET Devices, Production Volume (by Vendor)
Table 13: PET-CT Devices, Production Volume (by Region)
Table 14: PET-CT Devices, Production Volume (by Vendor)
Table 15: PET-MRI Devices, Production Volume (by Region)
Table 16: PET-MRI Devices, Production Volume (by Vendor)
Table 17: North America Brain Imaging Modalities Market, Regulatory Framework
Table 18: North America Brain Imaging Modalities Market, Impact Analysis
Table 19: Europe Brain Imaging Modalities Market Regulations
Table 20: Challenges in MDR Implementation
Table 21: Europe Brain Imaging Modalities, Impact Analysis
Table 22: Asia-Pacific Brain Imaging Modalities Market Regulations
Table 23: Asia-Pacific Brain Imaging Modalities Market, Impact Analysis
Table 24: Rest-of-the-World Brain Imaging Modalities Market Regulatory Framework
Table 25: Rest-of-the-World Brain Imaging Modalities Market, Impact Analysis
Table 26: Funding Activities, January 2017-December 2021
Table 27: Secondary Data Sources
Samples
LOADING...
Companies Mentioned
- Aspect Imaging
- Canon, Inc.
- Esaote SpA
- Fujifilm Holdings Corporation
- General Electric Company
- Hyperfine Inc.
- Koninklijke Philips N.V.
- Mediso Medical Imaging Systems
- MinFound Medical Systems Co., Ltd.
- Samsung Electronics Co., Ltd.
- Shenzhen Anke High-Tech Co.,Ltd.
- Shimadzu Corporation
- Siemens Healthineers AG
- United Imaging Healthcare Co., Ltd.
- VUNO Co., Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 216 |
| Published | February 2022 |
| Forecast Period | 2022 - 2031 |
| Estimated Market Value ( USD | $ 12963.1 Million |
| Forecasted Market Value ( USD | $ 20209.2 Million |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
